KDL Biotech (Delisted) share price
BSE: 532291
KDL Biotech Ltd. · Formerly Kopran Drugs · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary
Last traded ₹2.14 on 16 Mar 2015
Delisted on 11 May 2018.
Last announcements
The company's own last announcements before its shares stopped trading, routine notices left out.
May 2018
Jan 2018
Feb 2015
18 Feb · Results
13 Feb · Results
3 Feb · Board meeting
Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held February 10, 2015: (1) To transact the following business: 1. To consider and approve Un-audited Financial Results for the quarters ended June 30, 2013, September 30, 2013, December 31, 2013, March 31, 2014, June 30, 2014, September 30, 2014 & December 31, 2014. 2. To consider and approve Annual Accounts for the financial year ended March 31, 2013. 3. To consider fixing the date of convening the Annual General Meeting of the Members of the Company. The Company has now informed the Exchange that the due to unavailable reason the Board Meeting of the company which was scheduled to be held on February 10, 2015 has been rescheduled on February 12, 2015.Not held on this date
Results for the quarter to Dec 2014
Standalone: the listed company alone, without its subsidiaries. ₹ crore.
- Net profitNet profit. What is left of revenue and other income after every cost, interest and tax. Net profit in the glossary
- −₹3.33 Cr
From revenue to net profit, ₹ crore
- Other income0.0
- Finance costs−1.3
- Profit before tax−3.3
- Net profit−3.3
KDL Biotech results by quarter
Standalone: the listed company alone, without its subsidiaries. Latest quarter to Dec 2014. Results for the quarter to Mar 2015 were due by 30 May 2015, 60 days after it ends. Every company's dates are on the results calendar.
Revenue and net profit by quarter, ₹ crore
- Revenue
- Net profit
- Loss
Peak revenue ₹6.57 Cr, quarter to Sep 2012; lowest ₹0.99 Cr, quarter to Jun 2013A loss in 12 of the 12 quarters shown
Operating and net margin by quarter, per cent
- Operating margin
- Net margin
| ₹ crore | Mar 2010 | Jun 2010 | Sep 2010 | Dec 2010 | Mar 2011 | Jun 2011 | Sep 2011 | Dec 2011 | Mar 2012 | Jun 2012 | Sep 2012 | Dec 2012 | Mar 2013 | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 8.7 | 6.9 | 7.8 | 7.0 | 6.7 | 5.1 | 8.5 | 7.9 | 5.3 | 4.8 | 6.6 | 4.0 | 5.1 | 1.0 | – | – | – | – | – | – |
| Operating expenses. What the business spent to run itself in the period, materials, staff and other costs, before depreciation, interest and tax. Operating expenses in the glossary | 9.8 | 7.3 | 8.1 | 7.7 | 17.8 | 6.4 | 8.0 | 7.1 | – | 6.2 | – | 4.7 | – | 2.2 | – | – | – | – | – | – |
| Materials and goods boughtCost of materials and goods. Raw materials used and goods bought for resale in the period, adjusted for the change in stock held. Cost of materials and goods in the glossary | 2.6 | 2.2 | 2.1 | 1.5 | 0.9 | 0.9 | 1.4 | 1.1 | 1.3 | 1.2 | 1.6 | 1.0 | 1.2 | 0.1 | 0.0 | – | – | – | – | – |
| Employee costsEmployee costs. Salaries, wages, bonuses and other benefits paid to staff in the period. Employee costs in the glossary | 3.2 | 2.3 | 2.2 | 2.3 | – | 2.4 | 2.4 | 2.4 | – | 2.4 | – | 1.7 | – | 1.2 | – | – | – | – | – | – |
| Other expensesOther expenses. Every operating cost besides materials and staff: power, rent, freight, repairs, marketing and the like. Other expenses in the glossary | 4.0 | 2.8 | 3.8 | 3.9 | – | 3.2 | 4.1 | 3.6 | – | 2.7 | – | 2.1 | – | 0.9 | – | – | – | – | – | – |
| Operating profit before depreciationOperating profit before depreciation (EBITDA). Revenue less operating expenses: what the business earns from its operations before depreciation, interest and tax. Operating profit before depreciation (EBITDA) in the glossary | −1.1 | −0.4 | −0.3 | −0.7 | −11.1 | −1.4 | 0.5 | 0.8 | – | −1.4 | – | −0.7 | – | −1.2 | – | – | – | – | – | – |
| Operating margin | −12.2% | −5.2% | −4.1% | −10.0% | −166.1% | −27.5% | 6.4% | 10.5% | – | −29.0% | – | −17.9% | – | −124.8% | – | – | – | – | – | – |
| Depreciation and amortisationDepreciation and amortisation. The part of the cost of plant, buildings and other long-lived assets charged against each year they are used. Depreciation and amortisation in the glossary | 3.5 | 2.8 | 2.8 | 2.8 | 2.8 | 2.5 | 2.5 | 2.5 | – | 1.7 | – | 1.7 | – | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | – |
| Other incomeOther income. Income from outside the main business, such as interest on deposits, dividends received and gains on investments. Other income in the glossary | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 |
| Finance costsFinance costs. Interest and the other costs of borrowing in the period. Finance costs in the glossary | 0.5 | 0.4 | 0.5 | 0.5 | 5.3 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.2 | 1.2 | 1.3 |
| Profit before one-off items and taxProfit before one-off items and tax. Profit before tax as it would be without the one-off items below it, as the company states it. Profit before one-off items and tax in the glossary | −4.9 | −3.5 | −3.5 | −3.9 | −19.1 | −5.4 | −3.5 | −3.2 | −5.1 | −4.7 | −3.8 | −4.1 | −3.6 | −4.6 | −4.1 | −3.8 | −4.4 | −3.2 | −3.2 | −3.3 |
| One-off itemsExceptional items. Gains or losses the company reports separately because they are not expected to recur, such as selling a business or writing down an asset. Exceptional items in the glossary | – | – | – | – | −11.5 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Profit before tax | −4.9 | −3.5 | −3.5 | −3.9 | −30.6 | −5.4 | −3.5 | −3.2 | −5.1 | −4.7 | −3.8 | −4.1 | −3.6 | −4.6 | −4.1 | −3.8 | −4.4 | −3.2 | −3.2 | −3.3 |
| Tax | – | – | – | – | 7.7 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Net profit | −4.9 | −3.5 | −3.5 | −3.9 | −52.2 | −5.4 | −3.5 | −3.2 | −5.1 | −4.7 | −3.8 | −4.1 | −3.6 | −4.6 | −4.1 | −3.8 | −4.4 | −3.2 | −3.2 | −3.3 |
| Net margin | −55.8% | −50.6% | −45.0% | −55.3% | −782.7% | −107.5% | −41.4% | −40.4% | −96.1% | −97.6% | −57.8% | −102.1% | −70.3% | −464.7% | – | – | – | – | – | – |
| Earnings per shareEarnings per share. Profit belonging to shareholders divided by the number of shares, restated for later splits and bonuses so they do not break the line. Earnings per share in the glossary | – | – | – | – | – | – | – | – | −₹2.12 | −₹1.97 | −₹1.58 | −₹1.70 | −₹1.50 | – | – | – | – | – | – | – |
Earnings per share in rupees, restated for later splits and bonuses.
5 years at a glance
Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to September, then March.
Revenue, net profit and borrowings, ₹ crore
- Revenue
- Net profit
- Borrowings
- Loss
Peak revenue ₹41 Cr, year to Sep 2008; lowest ₹21 Cr, year to Mar 2013A loss in 4 of the 4 years with results on record
Operating and net margin, per cent
- Operating marginOperating margin. Operating profit before depreciation as a percentage of revenue: how much of each rupee of sales is left after running costs. Operating margin in the glossary
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
The company moved its year end from September to March: its last year to September on record ended in Sep 2008, its first year to March in Mar 2011.
Results for the year to Mar 2013
Standalone: the listed company alone, without its subsidiaries. ₹ crore.
From revenue to net profit
- Revenue21
- Materials and goods−5.0
- Employee costs−8.8
- Other expenses−9.6
- Operating profit−2.8
- Depreciation−6.9
- Other income+0.4
- Finance costs−6.9
- Profit before tax−16
- Net profit−16
Profit and loss
Standalone, ₹ crore, years to September, then March. No results on record for the year to Mar 2010.
| ₹ crore | Sep 2008 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 |
|---|---|---|---|---|---|
| Revenue from operations | 41.4 | – | 28.4 | 26.5 | 20.5 |
| 66.3 | – | 40.9 | – | 23.3 | |
| Materials and goods bought | 36.7 | – | 6.7 | 4.7 | 5.0 |
| Employee costs | 7.9 | – | – | – | 8.8 |
| Other expenses | 21.7 | – | – | – | 9.6 |
| Operating profit before depreciation | −24.9 | – | −12.5 | – | −2.8 |
| Operating margin | −60.3% | – | −43.9% | – | −13.7% |
| Materials, % of revenueMaterials, % of revenue. Raw materials used and goods bought for resale, adjusted for the change in stock, divided by revenue, times 100. Materials, % of revenue in the glossary | 88.7% | – | – | – | 24.2% |
| Employee costs, % of revenueEmployee costs, % of revenue. Salaries, wages and other staff costs divided by revenue, times 100. Employee costs, % of revenue in the glossary | 19.2% | – | – | – | 42.8% |
| Other expenses, % of revenueOther expenses, % of revenue. Operating costs besides materials and staff divided by revenue, times 100; with the two above and the operating margin it makes 100. Other expenses, % of revenue in the glossary | 52.4% | – | – | – | 46.6% |
| Depreciation and amortisation | 6.9 | – | 9.5 | – | 6.9 |
| Operating profit after depreciationOperating profit after depreciation (EBIT). Operating profit before depreciation, less depreciation and amortisation. Operating profit after depreciation (EBIT) in the glossary | −31.8 | – | −22.0 | – | −9.7 |
| Other income | 21.1 | – | 0.5 | 0.8 | 0.4 |
| Finance costs | 10.3 | – | 6.7 | 6.8 | 6.9 |
| Profit before one-off items and tax | −21.1 | – | −28.2 | −17.2 | −16.2 |
| One-off items | – | – | −11.5 | – | – |
| Profit before tax | −21.1 | – | −39.7 | −17.2 | −16.2 |
| Tax | 0.0 | – | 7.7 | – | – |
| Net profit | −21.1 | – | −61.4 | −17.2 | −16.2 |
| Net margin | −51.1% | – | −216.0% | −65.0% | −78.9% |
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2011 they do not, so they are left blank. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2012: the statement does not state its depreciation, which operating profit is worked out from, so operating profit is not given.
Ratios
Standalone, years to September, then March.
| Ratio | Mar 2012 | Mar 2013 |
|---|---|---|
| Revenue growthRevenue growth. This year's revenue less last year's, divided by last year's, times 100; blank where last year's is not above nought. Revenue growth in the glossary | −6.8% | −22.4% |
Interest cover is left blank for the years to Sep 2008, Mar 2011 and Mar 2013: operating profit after depreciation is a loss, and a loss covers no interest bill.
Growth and returns over 3, 5 and 10 years
Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2013.
| Measure | 3 years |
|---|---|
| Operating margin, averageOperating margin, average. 3 years: The plain average of the yearly operating profit margin over the last three years, needing at least two of them; a year without the figure is left out, never filled in. 5 years: The plain average of the yearly operating profit margin over the last five years, needing at least four of them; a year without the figure is left out, never filled in. 10 years: The plain average of the yearly operating profit margin over the last ten years, needing at least nine of them; a year without the figure is left out, never filled in. | −28.8% |
| Net margin, averageNet margin, average. 3 years: The plain average of the yearly net profit margin over the last three years, needing at least two of them; a year without the figure is left out, never filled in. 5 years: The plain average of the yearly net profit margin over the last five years, needing at least four of them; a year without the figure is left out, never filled in. 10 years: The plain average of the yearly net profit margin over the last ten years, needing at least nine of them; a year without the figure is left out, never filled in. | −120.0% |
Where the return came from
Yearly rates to Mar 2013, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −52.5% | – | – | 0.0% |
| 3 years | −46.5% | – | – | 0.0% |
| 5 years | −30.5% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record.
KDL Biotech share price by year
Each calendar year to 2015.
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2015BSE close | 2.14 | +32.1% | 2.25 | 1.70 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. The 2015 close is its last trade, on 16 Mar 2015.
Recent sessions
The 10 trading days to 16 Mar 2015, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 16 Mar 2015 | 2.14 | 2.14 | 2.14 | 2.14 | 2.14 | 4,811 |
| 9 Mar 2015 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 576 |
| 2 Mar 2015 | 2.15 | 2.15 | 2.15 | 2.15 | 2.15 | 1 |
| 23 Feb 2015 | 2.05 | 2.05 | 2.05 | 2.05 | 2.05 | 100 |
| 16 Feb 2015 | 1.90 | 1.98 | 1.90 | 1.98 | 1.93 | 800 |
| 9 Feb 2015 | 1.71 | 1.89 | 1.71 | 1.89 | 1.71 | 1,701 |
| 2 Feb 2015 | 1.77 | 1.80 | 1.77 | 1.80 | 1.78 | 150 |
| 19 Jan 2015 | 1.86 | 1.86 | 1.86 | 1.86 | 1.86 | 400 |
| 12 Jan 2015 | 1.78 | 1.78 | 1.78 | 1.78 | 1.78 | 770 |
| 5 Jan 2015 | 1.70 | 1.70 | 1.70 | 1.70 | 1.70 | 155 |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 12 Nov 2013 | Price move | – | Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for. |
| 12 Aug 2013 | Price move | – | Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for. |
Each event is noted and not adjusted for.
Company details
- BSE code
- 532291
- ISIN
- INE746A01010
- Former symbols
- KOPDRUGS
- Website
- www.kdlbiotech.com
- CIN
- L24230MH1986PLC040603
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 1986
- Registered office
- Village Savroli, Taluka Khalapur, Dist Raigad, Khopoli 410202, Maharashtra
- Share registrar
- Bigshare Services Pvt. Ltd
- Keeps the register of shareholders and handles transfers and dividend payments